Number of Shares
0
Holding current value
$0
% of portfolio
0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.96 - $82.35 $0 - $0
0 New
0 $0
Q2 2024

Nov 26, 2024

BUY
$62.12 - $84.15 $0 - $0
0 New
0 $0
Q1 2024

Nov 26, 2024

BUY
$65.98 - $77.09 $0 - $0
0 New
0 $0
Q4 2023

Nov 26, 2024

BUY
$52.83 - $78.22 $0 - $0
0 New
0 $0
Q3 2023

Nov 26, 2024

BUY
$67.52 - $89.42 $0 - $0
0 New
0 $0
Q2 2023

Nov 26, 2024

BUY
$73.76 - $85.98 $0 - $0
0 New
0 $0
Q1 2023

Nov 26, 2024

BUY
$71.62 - $86.62 $0 - $0
0 New
0 $0
Q4 2022

Nov 26, 2024

BUY
$80.67 - $352.29 $0 - $0
0 New
0 $0
Q3 2022

Nov 26, 2024

BUY
$282.54 - $391.85 $0 - $0
0 New
0 $0
Q2 2022

Nov 26, 2024

SELL
$322.67 - $449.65 $4.21 Million - $5.87 Million
-13,050 Closed
0 $0
Q1 2022

Nov 22, 2024

BUY
$353.85 - $487.79 $0 - $0
0 New
0 $0
Q4 2021

Nov 22, 2024

BUY
$456.15 - $525.06 $0 - $0
0 New
0 $0
Q3 2021

Nov 22, 2024

BUY
$444.87 - $538.88 $0 - $0
0 New
0 $0
Q2 2021

Nov 22, 2024

BUY
$387.35 - $450.26 $0 - $0
0 New
0 $0
Q1 2021

Nov 22, 2024

BUY
$314.62 - $411.0 $0 - $0
0 New
0 $0
Q4 2020

Nov 22, 2024

SELL
$246.9 - $321.87 $2.95 Million - $3.85 Million
-11,950 Closed
0 $0
Q3 2020

Nov 22, 2024

BUY
$232.22 - $282.96 $2.78 Million - $3.38 Million
11,950 New
11,950 $2.95 Billion
Q4 2019

Nov 22, 2024

BUY
$189.68 - $222.09 $2.48 Million - $2.9 Million
13,050 New
13,050 $2.85 Billion
Q1 2019

Nov 22, 2024

BUY
$136.09 - $200.44 $1.78 Million - $2.62 Million
13,050 New
13,050 $2.57 Billion
Q4 2018

Nov 26, 2024

BUY
$132.75 - $203.8 $1.73 Million - $2.66 Million
13,050 New
13,050 $1.85 Billion

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.